Recall report: Missing label, microbial contamination leads to recall of two batches of two drugs
Mylan Pharmaceuticals has recalled a batch of Semglee insulin pens after they were released without labels, the FDA said.
A single …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
